Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Tablets: SOP for Auditing Third-Party Manufacturers of Tablets – V 2.0

Posted on By

Tablets: SOP for Auditing Third-Party Manufacturers of Tablets – V 2.0

Standard Operating Procedure for Auditing Third-Party Manufacturers of Tablets

Department Tablet
SOP No. SOP/TAB/214/2025
Supersedes SOP/TAB/214/2022
Page No. Page 1 of 7
Issue Date 01/03/2026
Effective Date 06/03/2026
Review Date 01/03/2027

1. Purpose

This SOP provides the procedure for auditing third-party manufacturers of tablets to ensure compliance with GMP, regulatory guidelines, and company quality standards. It aims to assess manufacturing practices, quality control procedures, and documentation practices to ensure tablet products are safe, effective, and manufactured to required specifications.

2. Scope

This SOP applies to all third-party tablet manufacturers used by the company. It includes the auditing process for assessing manufacturing facilities, equipment, quality systems, and production practices, as well as evaluating compliance with regulatory requirements.

3. Responsibilities

  • Quality Assurance (QA) Manager: Responsible for overseeing the audit process, ensuring compliance, and reviewing audit reports.
  • Auditing Team: Responsible for conducting the audit, reviewing manufacturing and quality control procedures, and reporting findings.
  • Regulatory Affairs Team: Ensures that all auditing practices align with FDA, EMA, and other regulatory guidelines.
  • Procurement Team: Responsible for coordinating with third-party manufacturers to schedule audits and ensure timely completion of audit processes.

4. Accountability

The QA Manager is accountable for

the entire auditing process, from planning and conducting the audit to reviewing and finalizing the audit reports. The Auditing Team is responsible for carrying out the audit and documenting the findings, while the Procurement Team coordinates with third-party manufacturers.

See also  Tablets: SOP for Testing Thickness of Enteric Coating in Process - V 2.0

5. Procedure

5.1 Audit Planning

  1. Identify the third-party manufacturer to be audited based on a schedule or in response to a need (e.g., new supplier, product line change, recurring audit requirement).
  2. Determine the scope of the audit, which includes evaluating production facilities, manufacturing processes, equipment, and quality control measures (Annexure-1).
  3. Coordinate with the third-party manufacturer to schedule the audit and ensure availability of relevant personnel and documents.
  4. Prepare an audit checklist that includes key areas of focus, such as compliance with GMP, regulatory adherence, and quality control processes (Annexure-2).

5.2 Conducting the Audit

  1. Perform the audit according to the prepared checklist, covering areas such as:
    • Manufacturing environment (cleanliness, safety, and organization).
    • Production and equipment maintenance records.
    • Quality control practices, including raw material testing, in-process testing, and final product testing.
    • Compliance with regulatory requirements (FDA, EMA, etc.).
    • Documentation practices (batch records, deviation reports, CAPA records).
  2. Interview key personnel involved in manufacturing and quality control to assess their knowledge and compliance with established procedures.
  3. Examine records related to manufacturing, quality control, and validation (Annexure-3).

5.3 Identifying Non-Conformances

  1. During the audit, identify any non-conformances or gaps in compliance, including:
    • Failure to adhere to established procedures
    • Deficiencies in equipment calibration and maintenance
    • Inadequate training records or lack of qualified personnel
    • Out-of-specification results or failure to follow proper deviation handling procedures
  2. Document each non-conformance, including a description, impact assessment, and proposed corrective actions (Annexure-4).
See also  Tablets: SOP for Coating Machine Calibration and Setup - V 2.0

5.4 Reporting and Review

  1. Prepare an audit report that includes findings, non-conformances, and corrective actions, if necessary (Annexure-5).
  2. Review the audit report with the QA Manager and relevant teams to determine whether the third-party manufacturer is compliant or requires corrective actions.
  3. Share the audit report with the third-party manufacturer, outlining findings and requesting corrective actions for non-conformances (Annexure-6).

5.5 Corrective Actions and Follow-Up

  1. If non-conformances are identified, the third-party manufacturer must provide a corrective action plan (CAPA) to address the issues (Annexure-7).
  2. Review and approve the corrective action plan, ensuring that it adequately addresses the root causes of the deviations.
  3. Conduct a follow-up audit to verify that corrective actions have been implemented and are effective.
  4. Document the follow-up audit findings and report to the appropriate teams (Annexure-8).

5.6 Documentation and Record Keeping

  1. Ensure that all audit documents, including checklists, reports, and corrective action plans, are properly documented and stored for future reference (Annexure-9).
  2. Maintain records for a minimum of 5 years or as required by regulatory guidelines for auditing third-party manufacturers.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • GMP: Good Manufacturing Practice
  • CAPA: Corrective and Preventive Action
  • FDA: Food and Drug Administration

7. Documents

  1. Audit Checklist (Annexure-2)
  2. Audit Report (Annexure-5)
  3. Non-Conformance Log (Annexure-4)
  4. Corrective Action Plan (Annexure-7)
  5. Follow-up Audit Report (Annexure-8)
  6. Third-Party Manufacturer Audit Records (Annexure-9)
See also  Tablets: SOP for Tablet Dedusting Monitoring in Compression Process - V 2.0

8. References

  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
  • ISO 9001 – Quality Management Systems
  • GMP Guidelines for Pharmaceutical Manufacturing

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Audit Planning Template

Area of Focus Criteria Responsible Team
Manufacturing Facility Compliance with GMP Auditing Team

Annexure-2: Audit Checklist

Area Criteria Status Comments
Production Environment Cleanliness, safety Pass Well-maintained

Annexure-3: Audit Findings Report

Audit Finding Severity Action Required Due Date
Lack of training records High Provide training records 03/04/2026

Annexure-4: Non-Conformance Log

Non-Conformance ID Issue Impact Corrective Action
NC-001 Missing calibration records Possible equipment malfunction Complete calibration records

Annexure-5: Corrective Action Plan

Action ID Action Description Responsible Person Completion Date
CAP-001 Retrain staff on GMP Training Coordinator 01/04/2026

Annexure-6: Follow-up Audit Report

Audit Finding Resolution Follow-up Action
Lack of training records Training records completed Monitor training compliance

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP Creation QA Head
01/02/2025 2.0 Updated audit procedures Clarified responsibilities QA Head
Tablet Manufacturing V2.0 Tags:GMP tablet manufacturing SOP, SOP for tablet production, SOP for tablet quality control, SOP tablet inspection process, SOP tablet packing and sealing, Tablet batch record review, Tablet blending SOP, Tablet cleaning and maintenance, Tablet coating procedure, Tablet compression SOP, Tablet disintegration test procedure, Tablet dissolution procedure, Tablet formulation SOP, Tablet friability testing SOP, Tablet labeling and packaging SOP, Tablet manufacturing equipment SOP, Tablet manufacturing SOP, Tablet manufacturing SOPs, Tablet packaging SOP, Tablet production procedure, Tablet quality assurance SOP, Tablet quality control SOP, Tablet sampling and in-process testing SOP, Tablet stability testing SOP, Tablet storage and handling procedure, Tablet uniformity testing procedure, Tablet weight variation SOP

Post navigation

Previous Post: Creams: SOP for Operating Automatic Filling Machines for Creams – V 2.0
Next Post: BA-BE Studies: SOP for Protocol and SAP (Statistical Analysis Plan) Integration – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version